Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 Months
- 23 March 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (12) , 779-785
- https://doi.org/10.1056/nejm199503233321204
Abstract
We studied the efficacy of a short-course regimen of chemotherapy for pulmonary tuberculosis in Kinshasa, Zaire. We also assessed whether, among patients with human immunodeficiency virus (HIV) infection, treatment should be extended from 6 to 12 months.Keywords
This publication has 14 references indexed in Scilit:
- Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected UgandansThe Lancet, 1994
- Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in ZaireThe Lancet, 1993
- Mycobacterium tuberculosis in Household Contacts of Human Immunodeficiency Virus Type 1-Seropositive Patients with Active Pulmonary Tuberculosis in Kinshasa, ZaireThe Journal of Infectious Diseases, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment and Prevention of TuberculosisClinical Infectious Diseases, 1992
- Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 MonthsAmerican Review of Respiratory Disease, 1991
- Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- A 62-Dose, 6-Month Therapy for Pulmonary and Extrapulmonary TuberculosisAnnals of Internal Medicine, 1990
- USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and AcceptabilityAnnals of Internal Medicine, 1990
- Five-Year Follow-Up of a Clinical Trial of Three 6-Month Regimens of Chemotherapy Given Intermittently in the Continuation Phase in the Treatment of Pulmonary TuberculosisAmerican Review of Respiratory Disease, 1988
- Five-Year Follow-Up of a Controlled Trial of Five 6-Month Regimens of Chemotherapy for Pulmonary TuberculosisAmerican Review of Respiratory Disease, 1987